Anti-HIV Agents

DRUG3 trials

Sponsors

University of Alabama at Birmingham, University of Nebraska, CORPORACION DE LUCHA CONTRA EL SIDA

Conditions

Alcoholic HepatitisCirrhosis, LiverFibrosis, LiverHBVHIV InfectionHepatitis Delta VirusHepatocellular CarcinomaHuman Immunodeficiency Virus

Phase 4

EFFECTIVENESS AND SAFETY IN GENERIC ABACAVIR/LAMIVUDINE AND EFAVIRENZ IN HIV NAIVE PATIENTS

Active, not recruitingRPCEC00000202

CORPORACION DE LUCHA CONTRA EL SIDAHuman Immunodeficiency Viruses

Start: 2011-01-26Target: 40Updated: 2026-09-14

Unknown Phase

Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

CompletedNCT02344680

University of Alabama at BirminghamAlcoholic Hepatitis, Cirrhosis, Liver, Fibrosis, Liver +4

Start: 2015-10-01End: 2026-05-28Updated: 2026-07-02

The Lymphoid Tissue Pharmacology of Antiretroviral Drugs

WithdrawnNCT02707926

University of NebraskaHIV Infection

Start: 2023-03-25End: 2023-08-17Updated: 2023-08-24

Related Papers

Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: a nonrandomized, open-label, phase IV study in Cali-Colombia, 2011–2012

BMC Infectious Diseases2016-10-037 citations